TY - JOUR AU - Watson, P. A. AU - Arora, V. K. AU - Sawyers, C. L. PY - 2015 DA - 2015// TI - Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer JO - Nat Rev Cancer VL - 15 UR - https://doi.org/10.1038/nrc4016 DO - 10.1038/nrc4016 ID - Watson2015 ER - TY - JOUR AU - Mohler, J. L. AU - Gregory, C. W. AU - Ford, O. H. AU - Kim, D. AU - Weaver, C. M. AU - Petrusz, P. PY - 2004 DA - 2004// TI - The androgen axis in recurrent prostate cancer JO - Clin Cancer Res VL - 10 UR - https://doi.org/10.1158/1078-0432.CCR-1146-03 DO - 10.1158/1078-0432.CCR-1146-03 ID - Mohler2004 ER - TY - JOUR AU - Geller, J. AU - Albert, J. D. AU - Nachtsheim, D. A. AU - Loza, D. PY - 1984 DA - 1984// TI - Comparison of prostatic cancer tissue dihydrotestosterone levels at the time of relapse following orchiectomy or estrogen therapy JO - J Urol VL - 132 UR - https://doi.org/10.1016/S0022-5347(17)49829-6 DO - 10.1016/S0022-5347(17)49829-6 ID - Geller1984 ER - TY - JOUR AU - Nishiyama, T. AU - Hashimoto, Y. AU - Takahashi, K. PY - 2004 DA - 2004// TI - The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer JO - Clin Cancer Res VL - 10 UR - https://doi.org/10.1158/1078-0432.CCR-04-0913 DO - 10.1158/1078-0432.CCR-04-0913 ID - Nishiyama2004 ER - TY - JOUR AU - Stanbrough, M. AU - Bubley, G. J. AU - Ross, K. AU - Golub, T. R. AU - Rubin, M. A. AU - Penning, T. M. PY - 2006 DA - 2006// TI - Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-05-4000 DO - 10.1158/0008-5472.CAN-05-4000 ID - Stanbrough2006 ER - TY - JOUR AU - Montgomery, R. B. AU - Mostaghel, E. A. AU - Vessella, R. AU - Hess, D. L. AU - Kalhorn, T. F. AU - Higano, C. S. PY - 2008 DA - 2008// TI - Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-08-0249 DO - 10.1158/0008-5472.CAN-08-0249 ID - Montgomery2008 ER - TY - JOUR AU - Mohler, J. L. AU - Titus, M. A. AU - Bai, S. AU - Kennerley, B. J. AU - Lih, F. B. AU - Tomer, K. B. PY - 2011 DA - 2011// TI - Activation of the androgen receptor by intratumoral bioconversion of androstanediol to dihydrotestosterone in prostate cancer JO - Cancer Res VL - 71 UR - https://doi.org/10.1158/0008-5472.CAN-10-1343 DO - 10.1158/0008-5472.CAN-10-1343 ID - Mohler2011 ER - TY - JOUR AU - Ishizaki, F. AU - Nishiyama, T. AU - Kawasaki, T. AU - Miyashiro, Y. AU - Hara, N. AU - Takizawa, I. PY - 2013 DA - 2013// TI - Androgen deprivation promotes intratumoral synthesis of dihydrotestosterone from androgen metabolites in prostate cancer JO - Sci Rep VL - 3 UR - https://doi.org/10.1038/srep01528 DO - 10.1038/srep01528 ID - Ishizaki2013 ER - TY - JOUR AU - Chang, K. H. AU - Li, R. AU - Kuri, B. AU - Lotan, Y. AU - Roehrborn, C. G. AU - Liu, J. PY - 2013 DA - 2013// TI - A gain-of-function mutation in DHT synthesis in castration-resistant prostate cancer JO - Cell. VL - 154 UR - https://doi.org/10.1016/j.cell.2013.07.029 DO - 10.1016/j.cell.2013.07.029 ID - Chang2013 ER - TY - JOUR AU - Cai, C. AU - Chen, S. AU - Ng, P. AU - Bubley, G. J. AU - Nelson, P. S. AU - Mostaghel, E. A. PY - 2011 DA - 2011// TI - Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors JO - Cancer Res VL - 71 UR - https://doi.org/10.1158/0008-5472.CAN-11-0532 DO - 10.1158/0008-5472.CAN-11-0532 ID - Cai2011 ER - TY - JOUR AU - Powell, K. AU - Semaan, L. AU - Conley-LaComb, M. K. AU - Asangani, I. AU - Wu, Y. M. AU - Ginsburg, K. B. PY - 2015 DA - 2015// TI - ERG/AKR1C3/AR constitutes a feed-forward loop for AR signaling in prostate cancer cells JO - Clin Cancer Res VL - 21 UR - https://doi.org/10.1158/1078-0432.CCR-14-2352 DO - 10.1158/1078-0432.CCR-14-2352 ID - Powell2015 ER - TY - JOUR AU - Demichelis, F. AU - Fall, K. AU - Perner, S. AU - Andren, O. AU - Schmidt, F. AU - Setlur, S. R. PY - 2007 DA - 2007// TI - TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort JO - Oncogene. VL - 26 UR - https://doi.org/10.1038/sj.onc.1210237 DO - 10.1038/sj.onc.1210237 ID - Demichelis2007 ER - TY - JOUR AU - Wang, J. AU - Cai, Y. AU - Ren, C. AU - Ittmann, M. PY - 2006 DA - 2006// TI - Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-06-1966 DO - 10.1158/0008-5472.CAN-06-1966 ID - Wang2006 ER - TY - JOUR AU - Wang, J. AU - Cai, Y. AU - Yu, W. AU - Ren, C. AU - Spencer, D. M. AU - Ittmann, M. PY - 2008 DA - 2008// TI - Pleiotropic biological activities of alternatively spliced TMPRSS2/ERG fusion gene transcripts JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-08-1147 DO - 10.1158/0008-5472.CAN-08-1147 ID - Wang2008 ER - TY - JOUR AU - Tomlins, S. A. AU - Laxman, B. AU - Varambally, S. AU - Cao, X. AU - Yu, J. AU - Helgeson, B. E. PY - 2008 DA - 2008// TI - Role of the TMPRSS2-ERG gene fusion in prostate cancer JO - Neoplasia. VL - 10 UR - https://doi.org/10.1593/neo.07822 DO - 10.1593/neo.07822 ID - Tomlins2008 ER - TY - JOUR AU - Yu, J. AU - Mani, R. S. AU - Cao, Q. AU - Brenner, C. J. AU - Cao, X. AU - Wang, X. PY - 2010 DA - 2010// TI - An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression JO - Cancer Cell VL - 17 UR - https://doi.org/10.1016/j.ccr.2010.03.018 DO - 10.1016/j.ccr.2010.03.018 ID - Yu2010 ER - TY - JOUR AU - Zong, Y. AU - Xin, L. AU - Goldstein, A. S. AU - Lawson, D. A. AU - Teitell, M. A. AU - Witte, O. N. PY - 2009 DA - 2009// TI - ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells JO - Proc Natl Acad Sci U S A VL - 106 UR - https://doi.org/10.1073/pnas.0905931106 DO - 10.1073/pnas.0905931106 ID - Zong2009 ER - TY - JOUR AU - Cai, C. AU - Wang, H. AU - Xu, Y. AU - Chen, S. AU - Balk, S. P. PY - 2009 DA - 2009// TI - Reactivation of androgen receptor-regulated TMPRSS2:ERG gene expression in castration-resistant prostate cancer JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-09-0395 DO - 10.1158/0008-5472.CAN-09-0395 ID - Cai2009 ER - TY - JOUR AU - Wang, Q. AU - Li, W. AU - Zhang, Y. AU - Yuan, X. AU - Xu, K. AU - Yu, J. PY - 2009 DA - 2009// TI - Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer JO - Cell. VL - 138 UR - https://doi.org/10.1016/j.cell.2009.04.056 DO - 10.1016/j.cell.2009.04.056 ID - Wang2009 ER - TY - JOUR AU - Attard, G. AU - Swennenhuis, J. F. AU - Olmos, D. AU - Reid, A. H. AU - Vickers, E. AU - A'Hern, R. PY - 2009 DA - 2009// TI - Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-08-3667 DO - 10.1158/0008-5472.CAN-08-3667 ID - Attard2009 ER - TY - JOUR AU - Crnalic, S. AU - Hornberg, E. AU - Wikstrom, P. AU - Lerner, U. H. AU - Tieva, A. AU - Svensson, O. PY - 2010 DA - 2010// TI - Nuclear androgen receptor staining in bone metastases is related to a poor outcome in prostate cancer patients JO - Endocr Relat Cancer VL - 17 UR - https://doi.org/10.1677/ERC-10-0059 DO - 10.1677/ERC-10-0059 ID - Crnalic2010 ER - TY - JOUR AU - Hornberg, E. AU - Ylitalo, E. B. AU - Crnalic, S. AU - Antti, H. AU - Stattin, P. AU - Widmark, A. PY - 2011 DA - 2011// TI - Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0019059 DO - 10.1371/journal.pone.0019059 ID - Hornberg2011 ER - TY - JOUR AU - Zhang, X. AU - Morrissey, C. AU - Sun, S. AU - Ketchandji, M. AU - Nelson, P. S. AU - True, L. D. PY - 2011 DA - 2011// TI - Androgen receptor variants occur frequently in castration resistant prostate cancer metastases JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0027970 DO - 10.1371/journal.pone.0027970 ID - Zhang2011 ER - TY - JOUR AU - Russell, P. K. AU - Clarke, M. V. AU - Skinner, J. P. AU - Pang, T. P. AU - Zajac, J. D. AU - Davey, R. A. PY - 2012 DA - 2012// TI - Identification of gene pathways altered by deletion of the androgen receptor specifically in mineralizing osteoblasts and osteocytes in mice JO - J Mol Endocrinol VL - 49 UR - https://doi.org/10.1530/JME-12-0014 DO - 10.1530/JME-12-0014 ID - Russell2012 ER - TY - JOUR AU - Wiren, K. M. AU - Zhang, X. W. AU - Olson, D. A. AU - Turner, R. T. AU - Iwaniec, U. T. PY - 2012 DA - 2012// TI - Androgen prevents hypogonadal bone loss via inhibition of resorption mediated by mature osteoblasts/osteocytes JO - Bone. VL - 51 UR - https://doi.org/10.1016/j.bone.2012.08.111 DO - 10.1016/j.bone.2012.08.111 ID - Wiren2012 ER - TY - JOUR AU - Vanderschueren, D. AU - Vandenput, L. AU - Boonen, S. AU - Lindberg, M. K. AU - Bouillon, R. AU - Ohlsson, C. PY - 2004 DA - 2004// TI - Androgens and bone JO - Endocr Rev VL - 25 UR - https://doi.org/10.1210/er.2003-0003 DO - 10.1210/er.2003-0003 ID - Vanderschueren2004 ER - TY - JOUR AU - Efstathiou, E. AU - Titus, M. AU - Tsavachidou, D. AU - Tzelepi, V. AU - Wen, S. AU - Hoang, A. PY - 2012 DA - 2012// TI - Effects of abiraterone acetate on androgen signaling in castrate-resistant prostate cancer in bone JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2010.33.7675 DO - 10.1200/JCO.2010.33.7675 ID - Efstathiou2012 ER - TY - JOUR AU - Guerrero, J. AU - Alfaro, I. E. AU - Gomez, F. AU - Protter, A. A. AU - Bernales, S. PY - 2013 DA - 2013// TI - Enzalutamide, an androgen receptor signaling inhibitor, induces tumor regression in a mouse model of castration-resistant prostate cancer JO - Prostate. VL - 73 UR - https://doi.org/10.1002/pros.22674 DO - 10.1002/pros.22674 ID - Guerrero2013 ER - TY - JOUR AU - Fizazi, K. AU - Scher, H. I. AU - Miller, K. AU - Basch, E. AU - Sternberg, C. N. AU - Cella, D. PY - 2014 DA - 2014// TI - Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: results from the randomised, phase 3 AFFIRM trial JO - Lancet Oncol VL - 15 UR - https://doi.org/10.1016/S1470-2045(14)70303-1 DO - 10.1016/S1470-2045(14)70303-1 ID - Fizazi2014 ER - TY - JOUR AU - Loriot, Y. AU - Miller, K. AU - Sternberg, C. N. AU - Fizazi, K. AU - Bono, J. S. AU - Chowdhury, S. PY - 2015 DA - 2015// TI - Effect of enzalutamide on health-related quality of life, pain, and skeletal-related events in asymptomatic and minimally symptomatic, chemotherapy-naive patients with metastatic castration-resistant prostate cancer (PREVAIL): results from a randomised, phase 3 trial JO - Lancet Oncol VL - 16 UR - https://doi.org/10.1016/S1470-2045(15)70113-0 DO - 10.1016/S1470-2045(15)70113-0 ID - Loriot2015 ER - TY - JOUR AU - Chang, K. H. AU - Li, R. AU - Papari-Zareei, M. AU - Watumull, L. AU - Zhao, Y. D. AU - Auchus, R. J. PY - 2011 DA - 2011// TI - Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer JO - Proc Natl Acad Sci U S A VL - 108 UR - https://doi.org/10.1073/pnas.1107898108 DO - 10.1073/pnas.1107898108 ID - Chang2011 ER - TY - STD TI - Sbrissa D, Semaan L, Govindarajan B, Li Y, Caruthers NJ, Stemmer PM, et al. A novel cross-talk between CXCR4 and PI4KIIIα in prostate cancer cells. Oncogene. 2018. ID - ref32 ER - TY - JOUR AU - Liu, C. AU - Armstrong, C. M. AU - Lou, W. AU - Lombard, A. AU - Evans, C. P. AU - Gao, A. C. PY - 2017 DA - 2017// TI - Inhibition of AKR1C3 activation overcomes resistance to Abiraterone in advanced prostate cancer JO - Mol Cancer Ther VL - 16 UR - https://doi.org/10.1158/1535-7163.MCT-16-0186 DO - 10.1158/1535-7163.MCT-16-0186 ID - Liu2017 ER - TY - JOUR AU - Beltran, H. AU - Prandi, D. AU - Mosquera, J. M. AU - Benelli, M. AU - Puca, L. AU - Cyrta, J. PY - 2016 DA - 2016// TI - Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer JO - Nat Med VL - 22 UR - https://doi.org/10.1038/nm.4045 DO - 10.1038/nm.4045 ID - Beltran2016 ER - TY - JOUR AU - Li, Z. AU - Bishop, A. C. AU - Alyamani, M. AU - Garcia, J. A. AU - Dreicer, R. AU - Bunch, D. PY - 2015 DA - 2015// TI - Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer JO - Nature. VL - 523 UR - https://doi.org/10.1038/nature14406 DO - 10.1038/nature14406 ID - Li2015 ER -